Sun Pharma is buying Massachusetts-based Concert Pharmaceuticals Inc. for $576 million, a deal that will give India’s biggest pharma company access to the US company’s experimental drugs for treating skin diseases. The acquisition, which aims to strengthen Sun’s dermatology product range in the US, was approved by the boards of both companies and is expected to be completed in the first quarter of 2023.
The company had sought shareholders’ approval on the reappointment of Shiwani Singh, the wife of SpiceJet chairman and managing director Ajay Singh. Read more
The company had sought shareholders’ approval on the reappointment of Shiwani Singh, the wife of SpiceJet chairman and managing director Ajay Singh. Read more
In this week's podcast, India’s IT giants continued their pandemic-era growth spurt, with the Big 4 companies posting robust third-quarter numbers. Read more
In this week's podcast, India’s IT giants continued their pandemic-era growth spurt, with the Big 4 companies posting robust third-quarter numbers. Read more
In this week's episode, Sundeep Khanna talks about the latest in the corporate world including Jet's problems and the jumbo bond issue by Reliance. Read more
In this week's episode, Sundeep Khanna talks about the latest in the corporate world including Jet's problems and the jumbo bond issue by Reliance. Read more
The Website uses cookies to ensure you get the best experience on our website. If you continue browsing you will be providing your consent to our use of these.
